Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-2.00%
↑ 87% above average
Average (9y)
-15.16%
Historical baseline
Range
High:-2.00%
Low:-57.15%
CAGR
-28.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -2.00% | +52.1% |
| 2023 | -4.18% | +37.6% |
| 2022 | -6.70% | +50.0% |
| 2021 | -13.40% | -151.5% |
| 2020 | -5.33% | -24.2% |
| 2019 | -4.29% | -0.7% |
| 2018 | -4.26% | +69.6% |
| 2017 | -13.99% | +75.5% |
| 2016 | -57.15% | -41.9% |
| 2015 | -40.29% | - |